Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
|Active Ingredient:||Levetiracetam 100mg/mL|
|Dosage Form:||Solution for infusion|
|New Zealand Sponsor:||AFT Pharmaceuticals Limited|
|Manufacturers:||Pharmathen SA, Pallini, Greece
Mefar Ilac Sanayii A.S., Istanbul, Turkey
|Active Ingredient:||Atezolizumab 1200mg|
|Dosage Form:||Concentrate for infusion|
|New Zealand Sponsor:||Roche Products (NZ) Limited|
|Manufacturers:||Roche Diagnostics GmbH, Mannheim, Germany
F Hoffmann-La Roche Limited, Kaiseraugst, Switzerland
Dated this 21st day of October 2019.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).